医学
干细胞
旁分泌信号
再生医学
干细胞疗法
疾病
生物信息学
冠状动脉疾病
病理生理学
重症监护医学
神经科学
病理
内科学
移植
生物
遗传学
受体
作者
Charalampos Papastamos,Alexios S. Antonopoulos,Spyridon Simantiris,Νικόλαος Κούμαλλος,Panagiotis Theofilis,Μarios Sagris,Konstantinos Tsioufis,Emmanuel Androulakis,Dimitris Tousoulis
标识
DOI:10.2174/1381612829666230828102130
摘要
Over 20 years of intensified research in the field of stem cells brought about unprecedented possibilities in treating heart diseases. The investigators were initially fascinated by the idea of regenerating the lost myocardium and replacing it with new functional cardiomyocytes, but this was extremely challenging. However, the multifactorial effects of stem cell-based therapies beyond mere cardiomyocyte generation, caused by paracrine signaling, would open up new possibilities in treating cardiovascular diseases. To date, there is a strong body of evidence that the anti-inflammatory, anti-apoptotic, and immunomodulatory effects of stem cell therapy may alleviate atherosclerosis progression. In the present review, our objective is to provide a brief overview of the stem cell-based therapeutic options. We aim to delineate the pathophysiological mechanisms of their beneficial effects in cardiovascular diseases especially in coronary artery disease and to highlight some conclusions from important clinical studies in the field of regenerative medicine in cardiovascular diseases and how we could further move onwards.
科研通智能强力驱动
Strongly Powered by AbleSci AI